Elias Ugwu, MD
Nephrology · North Las Vegas, NVNPI 1942546296
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,726 of the $1,912 with a category attached, or 90.3%. Boehringer Ingelheim accounts for 90.7% of it on its own, with 3 other manufacturers making up the rest. 2022 is the largest year on record at $1,734, more than ten times the $122 reported in 2019.
Across 8 payments — averaging $238.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$2K
- Otsuka America Pharmaceutical, Inc.$122
- AbbVie$36
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$20
Across 21 payments — averaging $6107.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim International GmbH$79K
- Boehringer Ingelheim Pharma GmbH & Co.kg$49K
What the payments were for
- Travel & lodging$1,72690%
- Food & beverage$18610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 5 | $1,734 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| AbbVie | 1 | $36 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$1,726
- ABILIFY MAINTENA$122
How this compares
$1,912 in reported general payments places this provider in the 55th percentile of 125 nephrology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in North Las Vegas
- Samuel KantorLas Vegas$319K
- Richard CottieroLas Vegas$220K
- Mark VishnepolskyLas Vegas$68K
- Jusmin PatelReno$43K
- Mukesh SharmaReno$15K
- Sundar SankaranHenderson$13K
- Baishali NairLas Vegas$12K
- Gene OngLas Vegas$11K
- Jeffrey RyuLas Vegas$9K
- Luana PillonLas Vegas$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.